Humatech Stock

Humatech Current Assets

The Current Assets of Humatech (HUMT) as of Sep 2, 2026 is 184,000.00 USD. In the previous year, Current Assets was 54,000.00 USD — a change of 240.74% (higher).

Current Assets

184,000.00USD

YoY

240.74%

Last updated:

Current Assets of Humatech is 2026 184,000.00 USD. Current Assets of Humatech was 2025 54,000.00 USD. It decreases by 240.74% higher compared to the previous year.

The Humatech Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 1999
100,000.00 USD
Jan 1, 2000
550,000.00 USD
Jan 1, 2001
233,000.00 USD
Jan 1, 2002
174,000.00 USD
Jan 1, 2003
304,000.00 USD
Jan 1, 2004
60,000.00 USD
Jan 1, 2005
54,000.00 USD
Jan 1, 2006
184,000.00 USD
The Humatech Current Assets history
YEARCurrent AssetsYoY
184,000.00USD+240.74%
54,000.00USD-10.00%
60,000.00USD-80.26%
304,000.00USD+74.71%
174,000.00USD-25.32%
233,000.00USD-57.64%
550,000.00USD+450.00%
100,000.00USD-16.67%
120,000.00USD
Access this data via the Eulerpool API

Humatech Stock analysis

What does Humatech do? Humatech Inc is an international company that specializes in the development, production, and marketing of products for the healthcare industry. The company was founded in 1983 and has since adapted its business models and strategies to meet the changing demands of the market. It is now headquartered in Virginia, USA and operates on multiple continents. The business model of Humatech Inc focuses on the manufacturing of diagnostic and testing products for laboratory and clinical facilities. These products are designed for the diagnosis of diseases such as cancer, diabetes, pregnancy, thyroid problems, and many others. The company also offers HIV, hepatitis, and troponin tests. The high quality of these products has helped the company establish strong brand recognition and customer loyalty. In addition to its products, Humatech Inc also provides services in various areas to offer comprehensive solutions tailored to individual needs. These services include consulting, software solutions, and training, contributing to optimized and efficient operations in medical facilities and laboratories. The different divisions of Humatech Inc encompass a wide range of products and services. The category of diagnostic and testing products forms the core of the company, including tests for diabetes, pregnancy, thyroid problems, cancer, HIV, and hepatitis. The range also includes specialized tests for kidney problems and heart diseases. The company is constantly striving to expand its range of tests for new health issues. Under the category of consulting services, Humatech Inc offers in-depth knowledge of current medical developments, diagnostic procedures, and testing methods. Customers can choose from a wide range of services, including the development of specific test procedures, marketing support, and workflow optimization. The "software solutions" business field includes a variety of online tools to support diagnostic procedures and tests. The software allows medical facilities and laboratories to automate their workflow, manage and analyze data, and quickly retrieve test results. To provide customers with added value, Humatech Inc also offers a range of training programs. These not only cover the operation and application of the products, but also teach optimal work and result processes. Overall, Humatech Inc is an important player in the healthcare industry. By focusing on the development and marketing of diagnostic and testing products, the company is able to sustainably convince its customers through high product quality and services. The wide product range, services, and extensive network of employees, consultants, and customers make the company a forward-thinking service provider. Humatech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humatech stock

Current Assets of Humatech is 184,000.00 USD in 2026.

Current Assets of Humatech changed from 54,000.00 USD to 184,000.00 USD, representing a 240.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Humatech since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Humatech historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Humatech

All Key Metrics — Humatech